These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9123373)
21. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP Clin Transpl; 1996; ():257-64. PubMed ID: 9286575 [TBL] [Abstract][Full Text] [Related]
22. HLA-A, -B, and -DR matching contributes to graft survival in black recipients of renal allografts. Modiba MC; Wolf JS; Morse R; Lee A; Anderson B Transplant Proc; 1992 Oct; 24(5):1680-2. PubMed ID: 1412795 [No Abstract] [Full Text] [Related]
23. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients. Bućin D Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633 [TBL] [Abstract][Full Text] [Related]
24. Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation. Kaden J; Strobelt V; May G Transplant Proc; 1998 Dec; 30(8):4011-4. PubMed ID: 9865279 [No Abstract] [Full Text] [Related]
25. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect. Cicciarelli J; Terasaki PI; Cecka M; Mickey MR Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831 [No Abstract] [Full Text] [Related]
26. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Süsal C; Opelz G Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782 [TBL] [Abstract][Full Text] [Related]
27. Effect of HLA matching on graft survival in live donor kidney transplantations. Velidedeoğlu E; Bilgin N; Haberal M Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491 [No Abstract] [Full Text] [Related]
28. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine. Thorogood J; Schreuder GM; Persijn GG; van Rood JJ Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839 [No Abstract] [Full Text] [Related]
29. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies. Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834 [No Abstract] [Full Text] [Related]
30. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival. Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Solgi G Transplant Proc; 2015 May; 47(4):1110-3. PubMed ID: 26036531 [TBL] [Abstract][Full Text] [Related]
31. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy. Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807 [No Abstract] [Full Text] [Related]
32. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss. Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368 [No Abstract] [Full Text] [Related]